We are live on ! Find out more
OCBV

Ownership Capital B.V. Portfolio holdings

AUM $178M
1-Year Est. Return 4.75%
This Fund
S&P 500
This Quarter Est. Return
+10.01%
1 Year Est. Return
+4.75%
3 Year Est. Return
+62.8%
5 Year Est. Return
+49.32%
10 Year Est. Return
+389.93%
AUM
$8.6B
AUM Growth
+$908M
Cap. Flow
+$210M
Cap. Flow %
2.44%
Top 10 Hldgs %
61.11%
Holding
24
New
3
Increased
16
Reduced
4
Closed
1

Top Buys

Rank Stock Value
1
ABMD
Abiomed Inc
ABMD
+$185M
2
RMD icon
ResMed
RMD
+$93.4M
3
MRVI icon
Maravai LifeSciences
MRVI
+$90.3M
4
MKTX icon
MarketAxess Holdings
MKTX
+$60.7M
5
DXCM icon
DexCom
DXCM
+$46.9M

Top Sells

Rank Stock Value
1
V icon
Visa
V
+$252M
2
ANSS
Ansys
ANSS
+$38M
3
ICE icon
Intercontinental Exchange
ICE
+$34.4M
4
TW icon
Tradeweb Markets
TW
+$33.8M
5
MA icon
Mastercard
MA
+$26.3M

Sector Composition

Rank Sector Weight
1 Healthcare 35.03%
2 Financials 30.77%
3 Technology 26.82%
4 Industrials 3.99%
5 Real Estate 3.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MA icon
1
Mastercard
MA
$477B
$682M 7.93%
1,867,842
-70,705
-4% -$26.3M
MKTX icon
2
MarketAxess Holdings
MKTX
$4.15B
$606M 7.05%
1,307,678
+127,480
+11% +$60.7M
INTU icon
3
Intuit
INTU
$81.1B
$547M 6.36%
1,115,345
+30,834
+3% +$13.4M
EW icon
4
Edwards Lifesciences
EW
$47.6B
$508M 5.91%
4,905,616
+119,230
+2% +$11.2M
ANSS
5
DELISTED
Ansys
ANSS
$491M 5.71%
1,414,795
-109,827
-7% -$38M
PYPL icon
6
PayPal
PYPL
$49.5B
$490M 5.7%
1,681,193
+31,922
+2% +$8.43M
TECH icon
7
Bio-Techne
TECH
$11.2B
$489M 5.69%
4,344,524
+83,716
+2% +$8.81M
TW icon
8
Tradeweb Markets
TW
$21.3B
$486M 5.65%
5,746,608
-414,032
-7% -$33.8M
ILMN icon
9
Illumina
ILMN
$29.4B
$485M 5.64%
1,052,560
+19,477
+2% +$7.84M
MASI
10
DELISTED
Masimo
MASI
$470M 5.47%
1,939,045
+47,631
+3% +$10.9M
PTC icon
11
PTC
PTC
$13.7B
$429M 4.99%
3,037,179
+73,714
+2% +$10.1M
WDAY icon
12
Workday
WDAY
$33.4B
$425M 4.94%
1,780,350
+51,402
+3% +$12.4M
ICE icon
13
Intercontinental Exchange
ICE
$82.4B
$381M 4.43%
3,207,034
-298,646
-9% -$34.4M
TYL icon
14
Tyler Technologies
TYL
$12.2B
$373M 4.34%
825,597
+20,201
+3% +$8.58M
VRSK icon
15
Verisk Analytics
VRSK
$26.4B
$343M 3.99%
1,964,473
+48,060
+3% +$8.52M
RMD icon
16
ResMed
RMD
$28.3B
$331M 3.85%
1,341,339
+444,103
+49% +$93.4M
CSGP icon
17
CoStar Group
CSGP
$11.3B
$292M 3.4%
3,525,580
+85,630
+2% +$7.4M
BSX icon
18
Boston Scientific
BSX
$65.8B
$263M 3.06%
6,145,918
+150,385
+3% +$6.33M
ABMD
19
DELISTED
Abiomed Inc
ABMD
$189M 2.19%
+604,177
New +$185M
MTD icon
20
Mettler-Toledo International
MTD
$26.8B
$128M 1.49%
92,646
+2,258
+2% +$2.91M
MRVI icon
21
Maravai LifeSciences
MRVI
$997M
$97.2M 1.13%
+2,328,804
New +$90.3M
DXCM icon
22
DexCom
DXCM
$27.6B
$52.1M 0.61%
+488,112
New +$46.9M
APPF icon
23
AppFolio
APPF
$5.85B
$40M 0.46%
282,941
+6,897
+2% +$958K
V icon
24
Visa
V
$677B
-1,190,868
Closed -$252M

Similar funds

Ownership Capital B.V.'s Q2 2021 Portfolio in Review

As of Q2 2021, Ownership Capital B.V. held 24 positions worth $8.6B, up 12% from $7.69B the previous quarter. Its ten largest holdings account for 61% of the portfolio.

Ownership Capital B.V.'s Q2 2021 filing shows 3 new, 16 increased, 4 reduced and 1 closed positions. Its largest new stake was Abiomed Inc: 604,177 shares worth $189M. The largest sale was Visa, an estimated $252M.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, up from 28% a quarter earlier, followed by Financials and Technology.

  • Ownership Capital B.V.'s largest Q2 2021 buy was Abiomed Inc: 604,177 shares worth $189M.
  • Ownership Capital B.V. added most to ResMed in Q2 2021, an estimated $93.4M increase.
  • Ownership Capital B.V.'s biggest Q2 2021 reduction was Ansys, cutting an estimated $38M.
  • Ownership Capital B.V. fully exited Visa in Q2 2021, selling an estimated $252M.
  • Ownership Capital B.V.'s ten largest holdings make up 61% of its $8.6B portfolio in Q2 2021.
  • Ownership Capital B.V. opened 3 new positions and closed 1 in Q2 2021.
  • Ownership Capital B.V.'s portfolio value rose 12% quarter-over-quarter to $8.6B.

Based on Ownership Capital B.V.'s 13F filing for Q2 2021, filed 9 Aug 2021.